Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 2/20 | 0.41 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 5/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31444354 | 0.92 | MEN1 (0.39) | SLC5A1SLC5A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL31444317 | 0.85 | SLC5A2 (0.40) | SLC5A1SLC5A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL31444485 | 0.83 | RORC (0.39) | SLC5A1SLC5A2ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL18151450 | 0.81 | MEN1 (0.48) | ALDH1A1MEN1KMT2ABACE1 | |
| SCHEMBL31444487 | 0.77 | HCRTR2 (0.56) | SLC5A1SLC5A2HCRTR1HCRTR2MEN1 | |
| SCHEMBL14920390 | 0.73 | KMT2A (0.45) | ALDH1A1HCRTR1HCRTR2MEN1KMT2A | |
| SCHEMBL18150950 | 0.73 | KMT2A (0.50) | ALDH1A1MEN1KMT2A | |
| SCHEMBL20424244 | 0.69 | TDP1 (0.50) | ALDH1A1SMN1; SMN2MEN1KMT2ABACE1 | |
| SCHEMBL15989605 | 0.69 | MDM2 (0.51) | ALDH1A1HCRTR1HCRTR2MEN1KMT2A | |
| SCHEMBL15989606 | 0.69 | MDM2 (0.51) | ALDH1A1HCRTR1HCRTR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |